ABT vs PRMB · P/E 25, rev $44.33B vs P/E 127, rev $6.66B
Abbott Laboratories (ABT) versus Primo Brands Corporation (PRMB) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Primo Brands Corporation (PRMB) is a beverages - non-alcoholic company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported PRMB revenue for 2025-12-31 was $6.66B. Net income was $60.1M. Revenue was up 29.3% from 2024-12-31 to 2025-12-31. PRMB currently screens at market cap $8.78B and trailing P/E 127.3.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. PRMB currently screens at market cap $8.78B and trailing P/E 127.3.
Not investment advice. Open the ABT and PRMB stock pages for the full models.
Not investment advice.